Le Lézard
Classified in: Health
Subjects: SVY, MAT

New Analysis From CBD Oracle: Almost 1 in 3 States Have Banned Delta-8 THC

CBD Oracle releases state-by-state analysis of delta-8 THC's legal status, helping both the industry and consumers stay compliant and stay informed.

TUSTIN, Calif., Oct. 16, 2023 /PRNewswire/ -- CBD Oracle, a cannabis consumer research company, has released the first state-by-state map of delta-8 THC's legality that is both publicly available and reviewed for accuracy by an attorney. The 2018 Farm Bill and state laws that followed created a confusing patchwork of different regulatory schemes for hemp, and the new CBD Oracle map is designed to help the hemp industry and customers navigate current laws.

To view the full analysis, visit: https://cbdoracle.com/news/policy/delta-8-thc-legal/

CBD Oracle, working alongside Neil Willner, co-chair of the cannabis group at Royer Cooper Cohen Braunfeld, combed through the laws of each state and looked at the federal picture to produce the map.

Neil Willner comments, "Accurate information is an absolute necessity for any industry, let alone an industry that evolves on a seemingly daily basis like cannabis. Unfortunately, inaccurate information spreads like wildfire, especially in cannabis. CBD Oracle's mapping project provides an essential trusted source of information to rely on for both consumers and manufacturers alike."

The analysis found that 17 U.S. states have banned delta-8 THC, and seven others have severely restricted the cannabinoid. Bans in states like Colorado, Nevada and North Dakota target the "isomerization" process used to produce delta-8 THC from CBD, while others ? like California and Maryland ? only allow delta-8 THC in the regulated marijuana industry.

In 21 states and Washington D.C., delta-8 THC is broadly considered legal. Unfortunately, only a handful of these states (Alabama, Florida, Kentucky and Wyoming) have laws stating that delta-8 THC should only be sold to adults.

The map will be kept up-to-date as laws change, making it an invaluable resource for companies trying to stay compliant with both state and federal law. Compliance helps everyone, producing safer products, saving money on police enforcement and giving budding businesses a stable baseline to build from. CBD Oracle's map offers clarity for consumers and the industry, ensuring that nobody accidentally breaks the law.

About CBD Oracle

CBD Oracle is a consumer research company working to improve the safety and transparency of cannabis and hemp products, producing in-depth research pieces on cannabis and cannabinoids, along with analysis of social and legal issues.


These press releases may also interest you

at 16:20
Verastem Oncology, , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock,...

at 16:20
Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice President, Corporate Strategy and Chief Commercial Officer, will depart...

at 16:15
Exelixis, Inc. announced today that its second quarter 2024 financial results will be released on Tuesday, August 6, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss...

at 16:15
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced multiple updates for its taletrectinib program. Data from the global, pivotal Phase 2 TRUST-II study...

at 16:15
The Board of Directors of BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on September 30, 2024 to holders of record on...

at 16:05
Ligand Pharmaceuticals Incorporated today announced that it will report second quarter 2024 financial results after the close of the U.S. financial markets on Tuesday, August 6, 2024, and will hold a conference call at 4:30 p.m. Eastern Time that...

News published on and distributed by: